Instrument Inactif

Autres langues Diffusion Pharma

Actions

DFFN

US2537484048

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Diffusion Pharma : CervoMed Corporate Presentation December 2023	21/12
Diffusion Pharmaceuticals Inc.(NasdaqCM:DFFN) dropped from NASDAQ Composite Index	17/08/23
CervoMed Completes Merger with EIP Pharma	16/08/23
EIP Pharma, Inc. completed the acquisition of Diffusion Pharmaceuticals Inc. in a reverse merger transaction.	16/08/23
Diffusion Pharmaceuticals Shareholders Approve Merger With EIP Pharma; Shares Rise	15/08/23
Diffusion Pharmaceuticals Stockholders Approve Merger with EIP Pharma	15/08/23
Diffusion Pharmaceuticals : EIP Pharma Announces First Patient Dosed in RewinD-LB Phase 2b Clinical Trial Evaluating Neflamapimod in Dementia with Lewy Bodies - Form 8-K	14/08/23
Diffusion Pharmaceuticals : UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION - Form 8-K	09/08/23
Diffusion Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	08/08/23
Diffusion Pharmaceuticals : EIP Pharma to Present at Canaccord Genuity 43rd Annual Growth Conference - Form 8-K	03/08/23
Diffusion Pharmaceuticals Inc. Appoints Jill Davidson as A Director of the Company, Effective July 26, 2023	31/07/23
DIFFUSION PHARMACEUTICALS INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	21/06/23
Diffusion Pharmaceuticals Inc. Announces Resignation of William K. Hornung as CFO	19/05/23
DIFFUSION PHARMACEUTICALS INC. : Other Events, Financial Statements and Exhibits (form 8-K)	15/05/23
Diffusion Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/05/23
Diffusion Pharmaceuticals : EIP Pharma to Present at JMP Securities Life Sciences Conference - Form 8-K	11/05/23
Top Premarket Gainers	17/04/23
DIFFUSION PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Diffusion Pharmaceuticals Inc. - DFFN	01/04/23
Diffusion Pharmaceuticals, EIP Pharma Agree to Merge to Create New Combined Entity	30/03/23
DIFFUSION PHARMACEUTICALS INC. : Entry into a Material Definitive Agreement, Change in Directors or Principal Officers, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K)	30/03/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Diffusion Pharma

Actions

DFFN

US2537484048

Autres langues

Filtres